chr2-203956665-A-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BS1_Supporting
The NM_012092.4(ICOS):c.401A>C(p.Gln134Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000335 in 1,612,604 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. Q134Q) has been classified as Likely benign.
Frequency
Consequence
NM_012092.4 missense
Scores
Clinical Significance
Conservation
Publications
- common variable immunodeficiencyInheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- immunodeficiency, common variable, 1Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012092.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ICOS | NM_012092.4 | MANE Select | c.401A>C | p.Gln134Pro | missense | Exon 3 of 5 | NP_036224.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ICOS | ENST00000316386.11 | TSL:1 MANE Select | c.401A>C | p.Gln134Pro | missense | Exon 3 of 5 | ENSP00000319476.6 | ||
| ICOS | ENST00000435193.1 | TSL:1 | c.401A>C | p.Gln134Pro | missense | Exon 3 of 4 | ENSP00000415951.1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000836 AC: 21AN: 251198 AF XY: 0.0000663 show subpopulations
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1460430Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 726592 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74334 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 1 Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 134 of the ICOS protein (p.Gln134Pro). This variant is present in population databases (rs367905290, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with ICOS-related conditions. ClinVar contains an entry for this variant (Variation ID: 538689). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.401A>C (p.Q134P) alteration is located in exon 3 (coding exon 3) of the ICOS gene. This alteration results from a A to C substitution at nucleotide position 401, causing the glutamine (Q) at amino acid position 134 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at